In 38 people with chronic cluster headache, burst occipital nerve stimulation was not superior to placebo: ≥30% attack-frequency responders 18.81% vs 50.02%, favouring placebo (P=0.042). Eight treatment-related serious adverse events occurred.
RCTn = 38
Fogh-Andersen et al. Safety and efficacy of occipital nerve stimulation as treatment of chronic cluster headache: an investigator-initiated, double-blind, randomized, placebo-controlled study